| April 1 |
DiObex Announces Presentation of Scientific Poster at Annual
Meeting of American Society for Clinical Pharmacology and
Therapeutics |
| April 1 |
Elixir Medical Announces Positive Nine-Month Results From the
Excella Novolimus-Eluting Coronary Stent System First-In-Man Study |
| April 1 |
Cure HIV Reaches Out to Foundation Community to Fund LiSAVIOR |
| April 1 |
InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191
(R7227) and Provides Program Update |
| April 1 |
Phase III Studies of Investigational Trilipix (SLV348/ABT-335), In
Combination with Statins, Meets Primary Endpoints on Improving LDL,
triglycerides and HDL |
| April 1 |
Sirtris Pharmaceuticals Presents at American Chemical Society April
7 |
| April 1 |
AVANT's Single-Dose Oral Ty800 Vaccine Meets Primary Endpoints in
Phase 2 Study |
| April 1 |
New Data Showed Actos (pioglitazone HCl) Prevented Progression of
Atherosclerotic Plaque Volume in Patients with Type 2 Diabetes |
| April 1 |
ChemGenex Investigators Present Data on Clinical Activity of
Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia Patients
With the T315I Mutation at International Leukemia Conference |
| April 1 |
Bionovo Announces Publication of the Paper Detailing the Mechanism
of Action of Its Cancer Drug BZL101 |
| April 1 |
First Statin Monotherapy to Achieve Regression of Coronary
Atherosclerosis by Angiography in a Major Clinical Study |
| April 1 |
Study Confirms Anti-Infective ARIKACE Effectively Penetrates Mucus
and Biofilm, and Kills Pseudomonas, a Bacteria Plaguing Cystic
Fibrosis Patients |
| April 1 |
Significant Reductions in Mortality and Cardiovascular Events Shown
Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over |
| April 1 |
SurModics Announces First Human Use of SynBiosys Biodegradable
Polymer on CardioMind Drug-Eluting Stent |
| April 1 |
New Data Shows Ranexa Increases Glucose-Stimulated Insulin
Secretion |
| April 1 |
Final Data From the SEISMIC Trial Suggest Safety, Efficacy of
Autologous Stem- Cell Therapy for Treating Congestive Heart Failure |
| April 1 |
Merck's Investigational Rolofylline Associated with Improved
Dyspnea and Preserved Renal Function in Acute Heart Failure
Patients in a Phase III Pilot Study |
| April 1 |
Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients
with Chronic Stable Angina, According to New Study |
| April 1 |
TRITON Stent Analysis Data Presented at ACC. Eli Lilly and Company
and Daiichi Sankyo Company, Limited; MS&L |
| April 1 |
Trial starts of new modality of treating lung infections in Cystic
Fibrosis patients |
| April 1 |
Taxus Stent Demonstrates Similar Outcomes in Diabetic Patients
Compared to Non-diabetics in Pooled Analysis of TAXUS IV and V
Trials |
| April 1 |
Study Finds Taxus Drug-Eluting Stent Beneficial in Treatment of
Large Vessels |
| April 1 |
Nymox Releases Positive New Clinical Trial Data on Response Rates
to Company's Prostate Drug NX-1207 |
| April 1 |
SPP100 (tekturna/rasilez) Reduces Left Ventricular Hypertrophy |
| April 1 |
Latest Advances in Diabetes Research to be Presented in San
Francisco, California at World's Largest Diabetes Conference, June
6-10, 2008 |
| April 1 |
CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly
Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in
MERLIN-TIMI 36 Patients With Angina |
| April 1 |
ISTA Pharmaceuticals Announces Results of Clinical Trial of Xibrom
QD (Once-Daily) Formulation |
| April 1 |
Medicure Announces MEND-CABG II Study Results at the American
College of Cardiology Annual Scientific Session |
| April 2 |
Pfizer Announces Discontinuation of Phase III Clinical Trial for
Patients with Advanced Melanoma |
| April 2 |
Iodixanol vs Iopromide Study Abstract Presented at American College
of Cardiology 2008 |
| April 2 |
Kamada Announces That It Had Successfully Met the Primary Endpoint
in Its US Phase III Clinical Trial with Intravenous AAT |
| April 2 |
MediciNova to Present Additional Clinical Data Demonstrating
Potential Neuroprotection Benefits of MN-166 in Multiple Sclerosis
At the 18th Meeting of the European Neurological Society |
| April 2 |
Optimer Pharmaceuticals Announces Peer-Reviewed Publication of
OPT-80 Phase 1 Clinical Results for the Treatment of Clostridium
Difficile Infection |
| April 2 |
Clinical Update - Debio 0614 (Istaroxime) in Acute Heart Failure |
| April 2 |
Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program |
| April 2 |
Drug Does Not Appear to Reduce Risk of Heart Attack or Death
Following Coronary Artery Bypass Graft Surgery |
| April 2 |
Mixed Results in Clinical Trial of Weight Loss Drug Rimonabant on
Slowing Progression of Coronary Disease |
| April 2 |
Mayo Clinic Proceedings Examines a Possible Link Between Bacteria
Found in the Human Digestive System and Obesity |
| April 2 |
Bio-Rad Releases Poster That Describes Transfection Of Primary and
Difficult-to-Transfect Cells |
| April 2 |
Study Suggests Antiretroviral HIV Drug Linked to Increased Risk of
Heart Attack |
| April 2 |
One Of The World's Largest Heart Disease Studies Reveals How
Thousands Of Heart Attacks And Strokes Could Be Prevented Every
Year |
| April 2 |
Pantec Biosolutions unveils preclinical data for novel transdermal
drug delivery platform |
| April 2 |
Mayo Clinic Identifies Infection Risks for Patients with
Inflammatory Bowel Disease |
| April 3 |
Pharmacyclics Announces Multiple Presentations at the American
Association for Cancer Research Annual Meeting |
| April 3 |
Pivotal Phase 3 Data Show Denosumab Increased Bone Density at
Multiple Skeletal Sites in Early and Later Stage Postmenopausal
Women |
| April 3 |
Rib-X Pharmaceuticals to Present at 10th Annual Superbugs &
Superdrugs Conference |
| April 3 |
Advaxis Inc. to Present at the LD Micro Growth Conference in Los
Angeles, CA |
| April 4 |
Affymax and Takeda Report Long-Term Safety and Effectiveness Data
of Hematide in Chronic Renal Failure Patients With Anemia |
| April 4 |
Inspire Announces Poster Presentation at American Society of
Cataract and Refractive Surgery Annual Symposium |
| April 4 |
Data From Ortho Biotech-Sponsored Studies to be Presented at
National Kidney Foundation 2008 Spring Clinical Meetings |
| April 4 |
AMAG Pharmaceuticals, Inc. to Present Additional Positive Results
from Phase III Studies of Ferumoxytol as an Intravenous Iron
Replacement Therapeutic at National Kidney Foundation Spring
Clinical Meetings |
| April 4 |
Medicure Comments on Positive Aggrastat Results Presented at the
American College of Cardiology Annual Scientific Session |
| April 4 |
Momenta Pharmaceuticals Announces Presentation of M118 Phase 1
Results At the American Society for Clinical Pharmacology and
Therapeutics Annual Meeting |
| April 4 |
Prostate Cancer DNA Vaccine Results in Higher T-Cell Response When
Delivered via Inovio Biomedical's Electroporation Delivery System |
| April 4 |
Vaccine Induced Inflammation Linked to Epidemic of Type 2 Diabetes
and Metabolic Syndrome |
| April 4 |
Cystic Fibrosis Trial In Children Returns Positive Data |
| April 4 |
ACADIA Pharmaceuticals to Present Preclinical Data on ACP-104,
ACP-105 and Its Muscarinic Discovery Program at Experimental
Biology 2008 Meeting |
| April 4 |
Amgen's Oncology Pipeline Data Highlighted at Upcoming Scientific
Meeting |
| April 4 |
Neutropenia: Biosimilar Product from India Moves One Step Closer to
European Market |
| April 7 |
Cyclacel Pharmaceuticals Announces Multiple Presentations at
American Association of Cancer Research Annual Meeting |
| April 7 |
MediciNova Reports Clinical Results From Two-Year Phase II Clinical
Trial of MN-166 in Multiple Sclerosis |
| April 7 |
EpiCept Announces Positive Clinical Data from EPC2407 Phase I
Cancer Trial |
| April 7 |
Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase
Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences |
| April 7 |
Parion Sciences Announces Phase I Clinical Results for Novel Dry
Mouth Treatment |
| April 7 |
Biovitrum's Unique Neuropathic Pain Compound is Very Safe and Shows
Positive Effect |
| April 7 |
TaiGen Announces Positive Data From the Phase II Study of
Nemonoxacin (TG-873870) in Community-Acquired Pneumonia |
| April 7 |
Specialized Genasense Clinical Trials Featured at AACR Meeting |
| April 7 |
Recent siRNA Research Publications Support Silence Therapeutics
Combined Development Approach |
| April 7 |
Urigen Announces Early Closure of URG101 Phase II Clinical Trial
based on Positive Interim Analysis Results |
| April 7 |
NovaDel Announces Positive Data from Pilot Pharmacokinetic Study
Comparing Tizanidine Oral Spray to Zanaflex Tablets |
| April 7 |
H1N1 Influenza Virus With Highest Replikin Count Since the 1918
Pandemic Identified in the U.S. and Austria |
| April 7 |
Pluristem's Second Pre-Clinical Study in Ischemic Stroke Shows
Statistically Significant Advantages in Functional and Anatomical
Recovery |
| April 7 |
MediciNova Reports Clinical Results From Two-Year Phase II Clinical
Trial of MN-166 in Multiple Sclerosis |
| April 7 |
MediGene AG (DE) - MediGene Presents Details of the Excellent
Clinical Efficacy Data Obtained with EndoTAG-1 in the Indication
Pancreatic Carcinoma |
| April 7 |
New Data On Infinity's Lead Anti-Cancer Candidates to be Presented
At AACR |
| April 7 |
The GI Company to Present Phase I & II Oral Mucositis Data at
MASCC / ISOO Annual Meeting |
| April 8 |
Antisoma plc (UK) - Data on AS1411 action in breast cancer cells
published in Cancer Research |
| April 8 |
Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model |
| April 8 |
Preclinical Data on ARIAD's Novel Investigational mTOR Inhibitor,
Deforolimus, to Be Presented at the AACR Annual Meeting |
| April 8 |
Metabasis Therapeutics Presents the Discovery of Its
Second-Generation FBPase Inhibitor, MB07803, at the 235th American
Chemical Society National Meeting |
| April 8 |
ImmunoGen, Inc. Announces Presentations at the American Association
for Cancer Research 2008 Annual Meeting |
| April 8 |
GTx Announces Upcoming Presentation of Toremifene Citrate 80 mg
Phase III ADT Clinical Trial Results |
| April 8 |
MAP Pharmaceuticals Reports Positive Results From Phase 2a Clinical
Trial of Combination Therapy in Adult Asthmatics |
| April 8 |
ACZ885, a New Biological Drug in Development, Shows Potential in
Treating Serious Life-long Autoinflammatory Diseases |
| April 8 |
Phase III MS Neuropathic Pain Trial Preliminary Results |
| April 8 |
Telik Announces Preclinical Presentations at AACR Annual Meeting |
| April 8 |
New Clinical Data on AVEO Pharmaceuticals' Investigational Triple
VEGFR Small Molecule Inhibitor AV-951 to be Presented at AACR
Annual Meeting |
| April 8 |
ImQuest Scientists Present Important HIV Microbicide Development
Results at Microbicides 2008 in Delhi, India |
| April 8 |
Combination Drug Therapy May Hold the Key to Reversing Type 1
Diabetes |
| April 8 |
Critical Therapeutics Completes Phase I Clinical Trial of the R(+)
Isomer of Zileuton |
| April 8 |
Sirion Therapeutics Highlights Pivotal Trial Results of Durezol at
the American Society of Cataract and Refractive Surgery Annual
Symposium |
| April 9 |
Therapeutic Vaccine Company Inovio Biomedical Demonstrates Utility
of Its Electroporation Delivery Technology as Potent Vaccine
Adjuvant |
| April 9 |
Poniard Pharmaceuticals Announces Presentation of Clinical Data
From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be
Presented at 1st IASLC-ESMO European Lung Cancer Conference |
| April 9 |
Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual
Meeting of the American Association for Cancer Research |
| April 9 |
Barrier Therapeutics Announces Positive Results in Reducing Itch
Symptoms With Novel Oral Antihistamine Agent Hivenyl |
| April 9 |
Aeras, Crucell and South African Tuberculosis Vaccine Initiative
Announce Encouraging Preliminary Results of Tuberculosis Vaccine
Clinical Trial in South Africa |
| April 9 |
Cytopia Presentation on JAK2 Inhibitor at American Association for
Cancer Research |
| April 9 |
Idera Pharmaceuticals to Present Preclinical Data of its Toll-Like
Receptor-Targeted Compounds at AACR Meeting |
| April 9 |
Nektar Terminates All Negotiations With Potential Partners for
Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in
Ongoing Clinical Studies of Inhaled Insulin Patients |
| April 9 |
Nuvelo Announces Presentations on NU206 and rNAPc2 at 2008 American
Association for Cancer Research Annual Meeting |
| April 9 |
Curis Announces Presentations at American Association for Cancer
Research Annual Meeting 2008 |
| April 9 |
Xencor to Present New Data from CD19 Program at Upcoming Scientific
Meetings |
| April 9 |
Intra-Cellular Therapies Announces the Discovery of Potent
Antidepressant Activity in ITI-007/ITI-722 |
| April 9 |
PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A
Neuroprotective Role in Alzheimer's Disease |
| April 9 |
Seattle Genetics Highlights SGN-70 at AAI Annual Meeting |
| April 9 |
EpiCept Announces Multiple Presentations on ASAP Technology at
American Association of Cancer Research Annual Meeting |
| April 9 |
NSL-043 Achieves Phase I Trial Success |
| April 9 |
Kalos Therapeutics Data Confirming Anti-Cancer Effect of Naturally
Occurring Heart Hormones Presented at Experimental Biology 2008
Symposium |
| April 9 |
Arpida Invited to Present Data on Iclaprim at Scientific Conference |
| April 9 |
Oncolytics Biotech Inc. Reports Positive Interim Results of U.K.
Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial |
| April 9 |
Summit Presents the Benefits Zebrafish Bring to Drug Discovery and
Development at Two International Conferences |
| April 9 |
Physicians and Patients Nationwide Discuss Controversial Results of
Recent Cholesterol Lowering Study |
| April 9 |
Enzon to Present Preclinical Data On HIF-1alpha antagonist at AACR |
| April 9 |
Experimental Treatment for Type 1 Diabetes Patients Shows Promise |
| April 10 |
Inhibiton Therapeutics' Researcher to Present at American
Association for Cancer Research Annual Meeting |
| April 10 |
BTG Reports Positive Results from First Study Investigating
BGC20-0166 in Obstructive Sleep Apnoea Patients |
| April 10 |
Oncothyreon Announces Data from Multiple Small Molecule Programs to
be Presented at American Association of Cancer Research Annual
Meeting |
| April 10 |
MedImmune Presents Data Highlighting its Progressive Oncology
Portfolio at Annual Meeting of the American Association For Cancer
Research |
| April 10 |
Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to
Combat Hospital and Community Acquired Superbug Infections,
Including MRSA |
| April 10 |
Nektar Therapeutics to Present Positive Data at Upcoming Medical
and Scientific Meetings |
| April 10 |
MannKind Addresses Pfizer's Announcement Regarding Exubera |
| April 10 |
Further Research on Resveratrol Shows Promise for Treatment of
Pancreatic Cancer |
| April 10 |
Post-exposure Vaccination with Imvamune Protects Against Lethal
Poxvirus Infection |
| April 10 |
Haemacure Discloses Positive Results Of a Preclinical Study of Its
Fibrin Sealant in Adhesion Prevention and Opens a New Opportunity
in a Market with a Significant Unmet Medical Need |
| April 10 |
RNAi Efficacy Against ALS (Lou Gehrig's Disease) in a Research
Model Published in Peer-Reviewed Journal; RXi Pharmaceuticals
Exclusive Licensee of Research |
| April 10 |
Copaxone Significantly Reduced Annual Relapse Rates and Stabilized
Disease Progression in Relapsing Remitting Multiple Sclerosis
Patients Failing Interferon Treatment |
| April 10 |
Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of
Lead Compound MitoQ(R) |
| April 10 |
Access Pharmaceuticals to Present New Data on ProLindac at the AACR
Annual Meeting 2008 Conference |
| April 11 |
EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR
Annual Meeting |
| April 11 |
Napo Announces Successful Clinical Results in Phase 2 Study of
Crofelemer in Acute Adult Infectious Diarrhea |
| April 11 |
Santhera Presents Clinical Efficacy Data of SNT-MC17 in DMD at the
American Academy of Neurology Annual Meeting |
| April 11 |
Arpida Provides Further Comments on the Pivotal Phase III Trials |
| April 11 |
Algeta to Present New Preclinical Data on Cancer-Killing Effect of
Alpharadin (radium-223) at AACR |
| April 11 |
Vitamin K2 Linked to Lower Prostate Cancer Risk |
| April 11 |
Peregrine Pharmaceuticals Announces Four Upcoming Presentations at
the American Association for Cancer Research 2008 Annual Meeting |
| April 11 |
Study Shows Once-yearly Aclasta Better Than Risedronate at
Increasing Bone Mass in Patients with Osteoporosis Caused by
Glucocorticoids |
| April 11 |
Study Shows Once-Yearly Reclast Better than Risedronate at
Increasing Bone Mass in Patients With Osteoporosis Caused by
Glucocorticoids |
| April 11 |
Ortho Biotech Oncology Research & Development Unites Johnson
& Johnson Biopharmaceutical Oncology R&D Assets |
| April 11 |
Biovest Media Alert: Baltimore Sun Reports on First Patient
Worldwide to be Cured of Sickle Cell Disease Using Revimmune
Therapy for Bone Marrow Transplant |
| April 11 |
Parents Follow Pediatrician Advice on MMR Vaccinations |
| April 11 |
Bayhill Therapeutics Announces Presentation of MS Drug Candidate
BHT-3009 at American Academy of Neurology 60th Annual Meeting |
| April 11 |
Updated Data on Reata's Two Clinical Candidates Presented at 2008
Annual Meeting of the American Association of Cancer Research |
| April 14 |
Hollis-Eden Pharmaceuticals Presents Positive Data with APOPTONE in
Preclinical Bone Model of Late-Stage Prostate Cancer |
| April 14 |
Vaginal Progesterone is Equally Effective in Achieving Pregnancy
Outcomes as Injectable Progesterone in Donor Egg Cycles |
| April 14 |
Callisto Pharmaceuticals' Interim Phase II Data of Atiprimod in
Advanced Carcinoid Cancer to be presented at ASCO Conference |
| April 14 |
EntreMed's Kinase Inhibitor, ENMD-2076, Presented During AACR
Special Session |
| April 14 |
Cell Genesys Announces Encouraging Results from Phase 1/2 Trial of
GVAX Immunotherapy for Prostate Cancer in Recurrent Disease |
| April 14 |
Study Shows Intradigm's RNAi Nanoplex Technology To Be Effective
Systemic siRNA Delivery Platform for the Treatment of Various
Cancer Models |
| April 14 |
Update From Mipomersen Extended Dosing Study Continues to Show That
Mipomersen Is Well Tolerated and Maintains Activity in Patients
Treated for Up to 16 Months |
| April 14 |
Low HER2 Expressing Breast Cancer Patients Respond Preferentially
to Apthera's NeuVax |
| April 14 |
New Phase III Data Confirm Phase II Findings of Advexin Efficacy |
| April 14 |
U3 Pharma Achieves Preclinical Proof of Concept for U3-1287 (AMG
888) |
| April 14 |
YM Biosciences Announces Presentations for Two of Its Anti-cancer
Drugs at AACR Annual Meeting |
| April 14 |
The International Myeloma Foundation Says Revlimid Meets Important
Quality of Life Measures |
| April 14 |
The International Myeloma Foundation Says Revlimid Meets Important
Quality of Life Measures |
| April 14 |
BSI-201 Demonstrates Significant Tumor Growth Inhibition and
Increased Survival Rates in Preclinical Ovarian Cancer Studies |
| April 14 |
PG500 Series Presented at the AACR Annual Meeting in San Diego |
| April 14 |
Ardea Presents Preclinical Data on Novel Next Generation
Non-Nucleoside Reverse Transcriptase Inhibitors Demonstrating
Potent Anti-HIV Activity Against Resistant Viruses |
| April 14 |
Additive Anti-Tumor Activity of NKTR-102 in Combination With
Bevacizumab Highlighted in Positive Preclinical Data Presented at
AACR Meeting |
| April 14 |
SuperGen's MP-470 Sensitizes Prostate and Breast Cancer Cells to
Erlotinib |
| April 14 |
Karmanos Researchers Find Non-Toxic Agents Added to Conventional
Chemotherapy Decrease Survival of Colon Cancer Cells |
| April 14 |
Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent
Therapeutic Activity in Oral Mucositis Models |
| April 14 |
Alfacell's Onconase Shows Potential as Radiation Sensitizer for
Lung Cancer Treatment |
| April 14 |
TransMolecular Unveils First Data on TM601 Anti-Angiogenic
Mechanism-of-Action at AACR Annual Meeting |
| April 14 |
Curis Announces Preclinical Efficacy Data for CUDC-101 at AACR
Annual Meeting 2008 |
| April 14 |
ArQule Summarizes Abstracts Presented at AACR |
| April 14 |
ArQule Summarizes Abstracts Presented at AACR |
| April 14 |
Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent
Therapeutic Activity in Oral Mucositis Models |
| April 14 |
Stem Cells From Menstrual Blood Show Therapeutic Potential |
| April 14 |
Novelos Therapeutics and MUSC Present Poster at 2008 AACR Annual
Meeting |
| April 14 |
PhytoMedical Expands Anti-Cancer Research with Important Efficacy
Tests |
| April 14 |
Pluristem's PLX Cells Show a Statistically Significant Advantage in
a Pre-Clinical Study in the Multiple Sclerosis Model |
| April 14 |
AtheroGenics Announces Encouraging Interim Results |
| April 14 |
Immunomedics Reports Veltuzumab Enhances Radioimmunotherapy With
Epratuzumab in Lymphoma Model |
| April 14 |
Pharmacyclics Announces Preclinical Results Supporting Development
of Its Novel Btk Inhibitor in Immune Mediated Diseases |
| April 14 |
Curis Announces Preclinical Efficacy Data for CUDC-101 at AACR
Annual Meeting 2008 |
| April 14 |
Preclinical Study Presented at AACR Annual Meeting Shows Broad
Anti-Cancer Potential of Peregrine's anti-PS Vascular Targeting
Antibodies |
| April 14 |
Micromet Demonstrates That the Antibodies in Commercial Products
Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into
Highly Potent, T Cell- Engaging BiTE Antibodies |
| April 14 |
Micromet Shows Feasibility of Subcutaneous Delivery of BiTE
Antibody in Preclinical Primate Study |
| April 14 |
Micromet Presents Safety and Efficacy Data from Primate Studies
With Two New BiTE Antibodies Developed for Treatment of Leukaemia
and Melanoma |
| April 14 |
Semafore's PI3 Kinase Inhibitor SF1126 is a Vascular Targeted
Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple
Myeloma |
| April 14 |
Bionovo Identifies and Describes ER-beta Selective Compounds for
the Treatment of Vaginal Dryness |
| April 14 |
Calorie Restriction Limits and Obesity Fuels Development of
Epithelial Cancers |
| April 14 |
Cell Genesys Reports Preclinical Data Demonstrating Superior
Anti-Tumor Immunity for Multiantigen Compared to Single-Antigen
Immunotherapies |
| April 15 |
Spectrum Pharmaceuticals Presents Data on SPI-1620, a Novel Adjunct
to Chemotherapy, at the American Association of Cancer Research
Meeting |
| April 15 |
Oncolin Therapeutics Announces Its Lead Technology Has Shown to Be
Effective in Treating Cancer in Animal Models |
| April 15 |
Genentech and Biogen Idec Announce Top-Line Results from a Phase
II/III Clinical Trial of Rituxan in Primary-Progressive Multiple
Sclerosis |
| April 15 |
Callisto Pharmaceuticals Announces Presentation on SP-304 at the
3rd International Congress on Natural Peptides to Drugs |
| April 15 |
Pharmacopeia Announces Upcoming Late-Breaker Presentation of Phase
2a Results for Its First-in-Class Investigational DARA Compound,
PS433540 |
| April 15 |
Oncothyreon's PX-478 Enhances Antitumor Effects of Radiation
Therapy in Preclinical Models of Pancreatic and Brain Cancer |
| April 15 |
Arius Presents New Findings for Anti-cancer Antibody Programs at
AACR |
| April 15 |
Sunesis Pharmaceuticals Presents Nonclinical Data on SNS-595 at the
Annual Meeting of the American Association for Cancer Research |
| April 15 |
AVEO Pharmaceuticals’ Novel Triple VEGF Receptor Inhibitor
Shows Tumor Regression in Patients with Advanced Renal Cancer |
| April 15 |
Sangamo BioSciences Announces Presentation of Data on ZFP
Therapeutic for Glioblastoma at American Association for Cancer
Research (AACR) Meeting |
| April 15 |
Cancer Prevention: Stopping Cancer Before It Can Start |
| April 15 |
Active Biotech (SE) - Preclinical data presented for Active
Biotech's Anyara technology |
| April 15 |
Oculus Innovative Sciences Announces Publication of Microcyn
Technology Diabetic Wound Study in Journal of College of Physicians
and Surgeons Pakistan |
| April 15 |
Bionovo to Present Recent Findings of BN107 and BN108, Its
Anticancer Agents, at the American Association of Cancer Research |
| April 15 |
Transcept Pharmaceuticals: Study of Intermezzo by Leading Sleep
Expert Published in Human Psychopharmacology |
| April 15 |
ICLL: Investigational vaccine against JE shows excellent safety and
immunogenicity in Phase II trials in children |
| April 15 |
Positive Results from Phase I Clinical Trial of SMT D002 for the
Treatment of Seborrhoea, a Primary Cause of Acne |
| April 15 |
Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent
Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts
Metastasis in a Model of Hormone-Refractory Prostate Cancer |
| April 15 |
Aeolus Pharmaceuticals' AEOL 10150 Protects Lungs from Fractionated
Radiation; Reduces Angiogenesis and Inflammation |
| April 15 |
Optimer Pharmaceuticals Sponsors ECCMID Symposium on Clostridium
Difficile-Associated Disease: Current Treatments and Challenges |
| April 15 |
Inhibitex Presents Encouraging Phase I Data on FV-100 At 21st
International Conference on Antiviral Research |
| April 15 |
Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic
Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at
American Association for Cancer Research Conference |
| April 15 |
InNexus Biotechnology Presents Proof of Principle Data at AACR
Annual Meeting 2008 |
| April 15 |
SkyePharma Announces Positive Results of Flutiform Paediatric Study |
| April 15 |
Patients With Early Parkinson's Disease Show Better Symptom Control
and Improvements in Daily Activities with Stalevo Than
Levodopa/Carbidopa |
| April 15 |
Xanthus Presents Data Supporting Distinctive Mechanism of Action
for Xanafide |
| April 15 |
Callisto Pharmaceuticals Announces Presentation on SP-304 at the
3rd International Congress on Natural Peptides to Drugs |
| April 15 |
ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in
a Registrational Bioequivalence Clinical Study |
| April 15 |
Arius presents new findings for anti-cancer antibody programs at
AACR |
| April 15 |
Abraxis BioScience Presents New Preclinical Data Demonstrating
Eradication of Large Orthotopic Breast Tumors and Metastasis with
Combined nab-Paclitaxel (Abraxane) and Bevacizumab (Avastin)
Therapy |
| April 15 |
Seattle Genetics Presents Preclinical Data on its Antibody-Drug
Conjugate Technology and SGN-33 Program at AACR |
| April 15 |
Amgen Presents Preclinical and Clinical Data from Oncology Programs |
| April 15 |
Drugs in the Pipeline: New Therapies that Could Change Treatment
Strategies |
| April 15 |
Medarex Reports Interim Data from Ongoing Ipilimumab Combination
Phase 1 Studies in Prostate Cancer at American Association for
Cancer Research Meeting |
| April 15 |
Medivation's Dimebon Significantly Improved Daily Function in
Alzheimer's Disease Patients, Resulting in Reduced Need for
Caregiver Assistance |
| April 15 |
Immunotherapy: Enlisting the Immune System to Fight Cancer |
| April 15 |
New Data Published in Circulation Showed an Increase in HDL
Cholesterol Levels with Actos (pioglitazone HCl) |
| April 15 |
Nymox Nears Completion of Latest U.S. Study of NX-1207 for Benign
Prostatic Hyperplasia |
| April 15 |
Peregrine Researchers Present New Preclinical Data at AACR Annual
Meeting Confirming Unique Anti-Tumor Mechanism of Bavituximab |
| April 15 |
Advaxis Discloses Clinical Results of the First Ever Live Listeria
Monocytogenes Trial |
| April 15 |
Paloma Pharmaceuticals to Present at the American Association for
Cancer Research |
| April 15 |
Oncolytics Biotech Inc. Collaborators Present Reovirus Research for
Pediatric Sarcomas at AACR Annual Meeting |
| April 15 |
Preclinical Study Shows CTI's Brostallicin's Cancer-Killing Ability
Based on Genetic Profiling |
| April 15 |
Preclinical Study Presented at AACR Annual Meeting Shows
Peregrine's Anti-PS Immunocytokines Can Generate Protective Immune
Responses in a Highly Aggressive Breast Cancer Model |
| April 15 |
Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC
and Selective HDAC Inhibitors |
| April 15 |
ARIAD Presents Preclinical Deforolimus Data at American Association
for Cancer Research Meeting in Support of Clinical Initiatives |
| April 15 |
Study Shows that High-Dose, High-Frequency Interferon Produces no
Additional Benefit on Efficacy Compared to Avonex (interferon
beta-1a) in Patients with Relapsing-Remitting Multiple Sclerosis
(RRMS) |
| April 15 |
Seattle Genetics Presents Preclinical Data on its Antibody-Drug
Conjugate Technology and SGN-33 Program at AACR |
| April 15 |
First Fracture Prevention Study in Men Receiving ADT for Prostate
Cancer Presented at AACR Annual Meeting |
| April 15 |
GenVec Presents New Research on TNFerade |
| April 15 |
Oncolin Therapeutics Lead Cancer Technology is Being Presented
Today at the Annual Meeting of The American Association for Cancer
Research |
| April 15 |
Cell Genesys Reports Data on an Association Between Immune Response
and Anti-Tumor Activity in Patients Receiving GVAX Immunotherapy
for Prostate Cancer and Ipilimumab (MDX-010) |
| April 15 |
Biogen Idec and Elan Present New Tysabri Data at the 60th Annual
Meeting of the American Academy of Neurology |
| April 15 |
Opexa Therapeutics Presents Tovaxin Phase I/II Data at the American
Academy of Neurology 60th Annual Meeting |
| April 15 |
Oncolytics Biotech Inc. Collaborators Present Reovirus Research for
Multiple Myeloma at AACR Annual Meeting |
| April 16 |
Data Presented at AAN Show That Lacosamide Significantly Reduced
Pain and was Generally Well Tolerated in Patients With Diabetic
Neuropathic Pain |
| April 16 |
EntreMed Presents MKC-1 and ENMD-1198 Preclinical Data at AACR
Annual Meeting |
| April 16 |
ImmuneRegen Releases Results from UMDNJ Study Confirming Homspera's
Adult Stem Cell Activity |
| April 16 |
Oncolytics Biotech Inc. Announces Gene Therapy Publication on
Reovirus Treatment for Melanoma |
| April 16 |
Geron Presentations at the AACR 2008 Annual Meeting |
| April 16 |
Graceway Pharmaceuticals Reports Study in British Journal of
Dermatology: Patients Treated with ALDARA Experienced Higher Levels
of Histological and Sustained Clearance for Actinic Keratosis (AK)
than Patients in two Other Common AK Treatments |
| April 16 |
Lorus Therapeutics Presents New Findings for the Anticancer Drugs
LOR-253 and LOR-2040 |
| April 16 |
FTY720, a Novel Oral Therapy in Development for MS, Shows Sustained
Benefits for the Majority of Patients After Three Years of
Treatment |
| April 16 |
Sirtris Scientific Advisory Board Co-Chairs Publish First In-Vivo
Data Showing SIRT1 Enzyme Can Suppress Tumor Development |
| April 16 |
Data for Oncothyreon's PX-12 and PX-866 Presented at AACR Annual
Meeting |
| April 16 |
Medarex Reports Preclinical Data on Multiple Antibody-Drug
Conjugate Candidates at American Association for Cancer Research
Meeting |
| April 16 |
Amgen Presents Preclinical and Clinical Data from Oncology Programs |
| April 16 |
Amgen's Oncology Pipeline Data Highlighted at Upcoming Scientific
Meeting |
| April 16 |
Lyrica Reduced Pain of Fibromyalgia in Patients Regardless of
Symptoms of Anxiety or Depression |
| April 16 |
Preclinical Data Highlighting Potential of Retaspimycin in Treating
Non-Small Cell Lung Cancer With Acquired Drug Resistance Presented
by Infinity and MedImmune At AACR |
| April 16 |
Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr
Mechanisms of Action Published in PNAS |
| April 16 |
Laboratory Study Shows Naturally Occurring Antibodies Contained in
Gammagard Liquid May Bind to the Primary Culprit for Alzheimer's
Disease |
| April 16 |
AACR presentation illustrates broad potential of Antisoma's AS1411
in blood cancers |
| April 16 |
Novavax Reports Positive Results from Preclinical Studies of its
VLP-based Trivalent Seasonal Influenza Vaccine Candidate |
| April 16 |
Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of
SNS-032 at the Annual Meeting of the American Association for
Cancer Research |
| April 16 |
Halozyme Therapeutics Presents Findings on Combinations of rHuPH20
Enzyme With Bisphosphonates at the American Association for Cancer
Research Conference |
| April 16 |
Medarex Reports Preclinical Data on Multiple Antibody-Drug
Conjugate Candidates at American Association for Cancer Research
Meeting |
| April 16 |
ImQuest Presents New Anti-HIV Drug and Topical Microbicide
Development Results on Lead Pyrimidinedione Products IQP-0410 and
IQP-0528 |
| April 16 |
University of Virginia Study Shows That Lisofylline Reduces
Obesity-Related Inflammation and Insulin Resistance |
| April 16 |
Medicure Announces Presentation of Phase II Matched Results at
Cardiovascular Conference |
| April 16 |
Acadia Pharmaceuticals to Present Data from Its Phase II Trial with
Pimavanserin for Parkinson's Disease Psychosis at the 60th American
Academy of Neurology Annual Meeting |
| April 16 |
VioQuest Pharmaceuticals' Novel Akt Inhibitor VQD-002 is
Synergistic with Various Cancer Therapies in Preclinical Studies |
| April 16 |
Xanthus' Symadex Reverses Disease in Preclinical Mouse Models of
Multiple Sclerosis |
| April 16 |
Pharmacyclics' Novel Factor VIIa Inhibitor Demonstrates Potential
Inhibition of Tumor Growth in Multiple Types of Cancer |
| April 16 |
ZIOPHARM Presents Positive Data from Phase II Study of Darinaparsin
in Advanced Hematological Malignancies at AACR 2008 Annual Meeting |
| April 16 |
SuperGen Identifies Lead PIM Kinase Inhibitor, SGI-1776, That
Causes Tumor Regression in AML Xenograft Models |
| April 16 |
Cyclacel Pharmaceuticals presents insights into the mechanisms of
its cell cycle inhibitor drugs |
| April 16 |
Multiple Myeloma Research Consortium and Sunesis Pharmaceuticals
Present Data On SNS-032 At American Association of Cancer Research
Annual Meeting |
| April 16 |
OSI Pharmaceuticals Summarizes Data Presented at the Annual Meeting
of the American Association for Cancer Research |
| April 16 |
Celator Pharmaceuticals Successfully Uses Nanoparticles to
Administer Hydrophobic Drug Combinations |
| April 16 |
Schering-Plough Announces Imperfect Contraceptive Use Impacts
Women's Emotional Well-Being |
| April 16 |
Reclast better than Actonel at increasing bone mass in GIO patients |
| April 16 |
High Cholesterol in Your 40s Increases Risk of Alzheimer's Disease |
| April 16 |
Muscle Mass May Not Fully Explain Higher Creatinine in Blacks with
Kidney Disease |
| April 16 |
Bayhill Therapeutics Presents Data From a Phase II Trial of
BHT-3009 in Multiple Sclerosis at American Academy of Neurology
60th Annual Meeting |
| April 16 |
Novel Drug Delivery Methods: Getting Drugs to Tumors Quickly and
with Less Toxicity |
| April 17 |
Arpida Provides Comprehensive Overview of Pivotal Phase III Trial
Data |
| April 17 |
Methylgene Presents Preclinical Data for Its Multi-targeted (C-Met)
Kinase Inhibitor, Mgcd265, at AACR Annual Meeting |
| April 17 |
Medarex Reports Phase 1/2 Clinical Data of MDX-060 in Lymphoma at
American Association for Cancer Research Meeting |
| April 17 |
Lexicon's Drug Candidate for Rheumatoid Arthritis, LX2931, Shows
Positive Results in Phase 1 Clinical Trial |
| April 17 |
Kosan Presents Preclinical Data on Novel Third-Generation Hsp90
Inhibitors at AACR |
| April 17 |
Data Presented at the 60th Annual Meeting of the American Academy
of Neurology Offers Additional Support for Plasma Exchange as a
Potential Tool to Accelerate TYSABRI(R) Removal |
| April 17 |
Protox Announces Positive Long-term Data from BPH Study |
| April 17 |
Early Treatment with Copaxone Significantly Delayed Progression to
Clinically Definite Multiple Sclerosis |
| April 17 |
2nd Alzheimer¹s vaccine by AFFiRiS |
| April 17 |
Positive Results in First Clinical Study with Anti Diabetes
Compound Kb3305 |
| April 17 |
Access Pharmaceuticals Announces New Data on Angiolix |
| April 17 |
Spectrum Pharmaceuticals Presents Data on Lucanthone, a Novel
Anticancer Drug, at the Meeting of the American Association of
Cancer Research |
| April 17 |
Sirtris Announces SRT501 Lowers Glucose in Twice-Daily Dosing
Clinical Trial; Study Suggests Dose Response for Proprietary
Formulation of Resveratrol in Type 2 Diabetics |
| April 17 |
Results from Largest Statin Study of Patients with Alzheimer's
Disease Show Lipitor Has No Significant Impact on Disease |
| April 17 |
Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel
Anticancer Agents, at AACR |
| April 17 |
New Data Show Treatment of Multiple Sclerosis (MS) with Avonex
(interferon Beta-1a) Enhances Quality of Life |
| April 17 |
NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule
Inhibitor of Heat Shock Protein 90 (Hsp90) at the Annual Meeting of
the American Association for Cancer Research (AACR); Scientific
Advisory Board Chairman Tyler Jacks Named President-elect of AACR |
| April 17 |
Schering-Plough Highlights PegIntron and Boceprevir Data
Presentations at European Association for the Study of the Liver
(EASL) Annual Meeting |
| April 17 |
Pharmaceutical Ghostwriting Trend Mars Credibility of Research and
Negatively Impacts Patient Safety |
| April 17 |
New Hope for Migraine Sufferers: Optinose Nasal Delivery of
Sumatriptan Proves as Effective as Invasive Subcutantaneous
Injection |
| April 17 |
Nymox Announces Clinical Study Presentation on BPH Drug at American
Urological Association Meeting |
| April 17 |
Data Presented at the American Academy of Neurology Show
XP13512/GSK1838262 Significantly Improved Symptoms of
Moderate-to-Severe Primary Restless Legs Syndrome |
| April 17 |
Idera Pharmaceuticals Presents Data from Study of Toll-Like
Receptor Antagonist in Preclinical Model of Multiple Sclerosis |
| April 18 |
Anthera Presents Data on Varespladib at ATVB Meeting |
| April 18 |
Telik Presents Preclinical Data at 99th Annual Meeting of the
American Association for Cancer Research |
| April 18 |
Isotechnika's Canadian Phase 3 Psoriasis Trial Published in The
Lancet |
| April 18 |
Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside
Inhibitor of the HCV Polymerase, at the 21st International
Conference on Antiviral Research |
| April 18 |
Copaxone Significantly Reduced Brain Atrophy and Tissue Loss over
Five Years in Treatment-Naive Relapsing-Remitting Multiple
Sclerosis Patients |
| April 18 |
Isis Reports Reduction of apoB-100 Levels in a Murine Model
Resulting in Up to 92% Reduction of Atherosclerosis |
| April 18 |
Herceptin Helps Eradicate HER2-Positive Breast Tumours When Given
Before Surgery |
| April 18 |
Using Anticholinergic Drugs May Increase Cognitive Decline in Older
People |
| April 18 |
Data Presented at AAN Support Potential for Adjunctive use of
Intravenous Lacosamide as Short-Term Replacement for Oral Treatment
in Partial Epilepsy |
| April 18 |
Advaxis' Listeria Monocytogenes-Based Vaccine Garners National
Media Attention |
| April 18 |
FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data
to the American Association for Cancer Research |
| April 18 |
Novel Xeloda Dosing Schedule May Offer Well-Tolerated Alternative
for Treatment of Advanced Breast Cancer |
| April 21 |
Medivation's Dimebon Significantly Improved Thinking and Memory in
Alzheimer's Disease Patients Over One Year |
| April 21 |
New scientific data on ceftobiprole and isavuconazole will be
presented at ECCMID |
| April 21 |
Genentech Provides Update on ''AVAiL'' Phase III Study of Avastin
Plus Chemotherapy in First-Line, Advanced, Non-Squamous, Non-Small
Cell Lung Cancer |
| April 21 |
Targanta Announces Highlights of Oritavancin Data to Be Presented
at the 18th ECCMID |
| April 21 |
Targanta Announces Launch of Oral Oritavancin Development Program
against C. Difficile Bacterial Infection |
| April 21 |
Graceway Pharmaceuticals Reports Study in New England Journal of
Medicine: Aldara (imiquimod) Cream, 5% demonstrated a reduction in
lesion size in patients with vulvar intraepithelial neoplasia |
| April 21 |
New antibiotic class proves effective against MRSA |
| April 21 |
Sirion Therapeutics Preclinical Studies: Two New Potential Advances
in Treatment of Retinal Diseases to be Presented at ARVO |
| April 21 |
ACORN Presents Findings of Collaborative Metastatic Colorectal
Cancer Research |
| April 21 |
Liver Phase I Abstract to Be Presented At WCIO 2008 & Best Of
ASCO |
| April 21 |
Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy
With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer |
| April 21 |
Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy
with No Dose Limiting Toxicity in Metastatic Pancreatic Cancer;
Second Phase Opens with Higher Dose Regimens |
| April 21 |
BioAlliance Pharma Announces Preliminary Results from the Pivotal
US Phase III Trial for Loramyc |
| April 21 |
High-Dose Lipitor Reduced the Risk of Heart Attack and Stroke in
Patients with Chronic Kidney Disease |
| April 22 |
Dosing for RVX-208 Phase 1a Clinical Study Completed |
| April 22 |
Chelsea Announces Publication of Clinical Autonomic Research
Supplement Focusing On Neurogenic Orthostatic Hypotension |
| April 22 |
Elusys' Anthim Dramatically Improves Survival of Animals Treated
After Active Anthrax Infection |
| April 22 |
Strativa Pharmaceuticals Announces Phase III Results for Loramyc to
Treat Oropharyngeal Candidiasis |
| April 22 |
Study in JAMA Shows Patients Treated With Abbott's Xience V Drug
Eluting Stent Experience Better Outcomes Than Patients Treated With
Market-Leading Drug Eluting Stent |
| April 23 |
La Jolla Pharmaceutical Announces Positive 12-Month Interim
Antibody Data and Provides Update for Ongoing Riquent(R) Phase 3
'ASPEN' Lupus Trial |
| April 23 |
Inspire to Discontinue Development of Epinastine Nasal Spray |
| April 23 |
Oral PBI-1402 Demonstrates Significant Activity in
Chemotherapy-Induced Anemia Phase II Clinical Trial |
| April 23 |
Poniard Pharmaceuticals Announces Final Picoplatin Data from Phase
2 Small Cell Lung Cancer Trial Demonstrating Survival Benefit |
| April 23 |
Telaprevir-Based PROVE Studies Show Significantly Higher SVR Rates
in Treatment-Naive Genotype 1 Hepatitis C Patients in Half the Time
of Current Treatments |
| April 23 |
Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV
Programs at The Annual Meeting of The European Association for the
|
